SEC 13F Intelligence

Frazier Management LLC / ARQT

Frazier Management LLC’s Arcutis Biotherapeutics Inc Position

Does Frazier Management LLC own Arcutis Biotherapeutics Inc (ARQT)? Not currently — the last reported position was 8.43M shares worth $175M in Q4 2021; the fund’s latest 13F (Q3 2022) no longer reports it.

Position Value
$175M
Q4 2021
Shares
8.43M
% of Portfolio
+13.47%
Quarters Held
8
position exited

Position History ARQT

Reported value by quarter
Q1 ’20: $314MQ1 ’20Q2 ’20: $319MQ2 ’20Q3 ’20: $309MQ3 ’20Q4 ’20: $297MQ4 ’20Q1 ’21: $305MQ1 ’21Q2 ’21: $230MQ2 ’21Q3 ’21: $201MQ3 ’21Q4 ’21: $175MQ4 ’21filingsflow.com
QuarterSharesValue% of Portfolio
Q4 20218.43M$175M+13.47%
Q3 20218.43M$201M+16.12%
Q2 20218.43M$230M+21.23%
Q1 202110.54M$305M+24.46%
Q4 202010.54M$297M+22.84%
Q3 202010.54M$309M+27.73%
Q2 202010.54M$319M+28.00%
Q1 202010.54M$314M+35.62%

Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Frazier Management LLC’s full portfolio or all institutional holders of ARQT.